Reversed-phase high-performance liquid chromatography of 4-(2-pyridyl)- 1-piperazinethiocarboxylic acid 2-[1-(pyridyl)ethylidene]hydrazide dihydrochloride (NSC 348977), a synthetic thiosemicarbazone with antitumor activity

Journal of Chromatography B: Biomedical Applications

Volumn 708, Issue 1-2, 1998, Pages 217-222

  Lunn, George ^a,b   Phillips, Lawrence R ^a   Pacula Cox, Christine ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

NSC 348977; Thiosemicarbazone

Indexed keywords

4 (2 PYRIDYL) 1 PIPERAZINETHIOCARBOXYLIC ACID 2 [1 (PYRIDYL)ETHYLIDENE]HYDRAZIDE; ACETONITRILE; ANTINEOPLASTIC AGENT; EDETIC ACID; NSC 378977; POTASSIUM DIHYDROGEN PHOSPHATE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DENATURATION; DRUG DETERMINATION; DRUG ISOLATION; MOUSE; NONHUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDRAZONES; MICE; PIPERAZINES;

EID: 0032562417     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00637-3     Document Type: Article

References (20)

1. Hambre D., Bernstein J., Donovick R. Proc. Soc. Exper. Biol. Med. 73:1950;275.
2. Brownlee K.A., Hambre D. J. Bacteriol. 61:1951;127.
3. Hambre D., Brownlee K.A., Donovick R. J. Immunol. 67:1951;305.
4. Thompson R.L., Minton S.A., Officer J.E., Hitchings G.H. J. Immunol. 70:1953;229.
5. Saripinar E., Güzel Y., Patat S., Yildirim I., Akçamur Y., Dimoglo A.S. Arzneim.-Forsch. 46:1996;824.
6. Brockman R.W., Thomson J.R., Bell M.J., Skipper H.E. Cancer Res. 16:1956;167.
7. Wilson H.R., Revankar G.R., Tolman R.L. J. Med. Chem. 17:1974;760.
8. Mathew M., Palenik G.J. J. Am. Chem. Soc. 91:1969;6310.
9. Singh R.B., Ishii H. Crit. Rev. Anal. Chem. 22:1991;381.
10. Scovill J.P., Klayman D.L., Franchino C.F. J. Med. Chem. 25:1982;1261.
11. Saryan L.A., Ankel E., Krishnamurti C., Petering D.H., Elford H. J. Med. Chem. 22:1979;1218.
12. Klayman D.L., Scovill J.P., Bartosevich J.F., Mason C.J. J. Med. Chem. 22:1979;1367.
13. Dobek A.S., Klayman D.L., Dickson E.T., Scovill J.P., Tramont E.C. Antimicrob. Agents Chemother. 18:1980;27.
14. D.L. Klayman, J.P. Scovill, J.F. Bartosevich, C.J. Mason and R.S. Griffin, US Pat., 4 317 776 (1982).
15. Lambrow C., Childs G.E., Notsch J.D., Scovill J.P., Klayman D.L., Davidson D.E. Antimicrob. Agents Chemother. 22:1982;981.
16. Collins F.M., Klayman D.L., Morrison N.E. J. Gen. Microbiol. 128:1982;1349.
17. Casero R.A., Klayman D.L., Childs G.E., Scovill J.P., Desjardins R.E. Antimicrob. Agents Chemother. 18:1980;317-322.
18. Shipman C., Smith S.H., Drach J.C., Klayman D.L. Antiviral Res. 6:1986;197.
19. Klayman D.L., Lin A.J., McCall J.W., Wang S.-Y., Townson S., Grogl M., Kinnamon K.E. J. Med. Chem. 34:1981;1422.
20. Klayman D.L., Scovill J.P., Mason C.J., Bartosevich J.F., Bruce J., Lin A.J. Arzneim.-Forsch. 33:1983;909.